GoldBamboo.com - Knowledge is strong medicine
  

Capecitabine - Blogs


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:





Capecitabine

Xeloda 



Recent Blog Posts



View Post: Capecitabine (Xeloda) for Early Stage Breast Cancer in the Elderly ...
24 Jul 2009 by Dr. Charles Balch  
Capecitabine (XELODA, Roche) is the first FDA-approved oral chemotherapy for the treatment of both metastatic breast and colorectal cancers. The drug is approved for use in colorectal cancer, both as adjuvant therapy after surgery for ...
View Blog: My Cancer Advisor - http://mycanceradvisor.com/



View Post: Med-Chemist: Capecitabine combination therapy reduces early breast ...
17 Nov 2009 by Syn-chemist  
Capecitabine is a prodrug, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. The activation of capecitabine follows a pathway with three enzymatic steps and ...
View Blog: Med-Chemist - http://synchemist.blogspot.com/



View Post: Landmark Study in The Lancet Oncology Shows Capecitabine (Xeloda(R ...
11 Nov 2009
Finland November 11 /- ... - This is a third party press release. It will be issued by the Fi... - FinXX a Large Phase III Randomised Study in Women With Early B... An analysis conducted by the Finnish Breast Cancer Group and publi... ...
View Blog: Latest Medical Technology from Bio-Medicine.Org - http://www.bio-medicine.org/medicine-technology...



View Post: Capecitabine reduces breast cancer recurrence « pharma news
12 Nov 2009 by HSPDi  
The analysis, conducted by the Finnish Breast Cancer Group and published in The Lancet Oncology, shows that the addition of capecitabine (Xeloda) to treat women at intermediate to high risk of early breast cancer recurrence reduced the ...
View Blog: pharma news - http://www.pharmajobs.co.uk/blog/



View Post: Landmark study in The Lancet Oncology shows capecitabine (Xeloda ...
10 Nov 2009
Landmark study in The Lancet Oncology shows capecitabine (Xeloda®) combination therapy reduces early breast cancer recurrence FinXX, a large, phase III randomised study in women with early breast cancer shows that adding capecitabine ...
View Blog: Latest Clinical Research Jobs - http://www.pharmiweb.com/



View Post: RCT: Adjuvant capecitabine in combination with docetaxel and ...
10 Nov 2009
An open label RCT has examined whether integration of capecitabine into standard adjuvant chemotherapy regimens typically comprising a taxane, an anthracycline, and cyclophosphamide, for patients with moderate-to-high-risk early breast ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/



View Post: Dose Finding and Early Efficacy Study of Gemcitabine Plus ...
18 Nov 2009 by Starling, Watkins, Cunningham, Thomas,...  
This study evaluated safety and efficacy of chemotherapy (gemcitabine plus capecitabine) plus bevacizumab/erlotinib in advanced pancreatic cancer because dual epidermal growth factor receptor/vascular endothelial growth factor blockade ...
View Blog: Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/



Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

GoldBambooTM

Your Integrative Health and Wellness Resource for Capecitabine.

November 26, 2009



Page Updated: September 6, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.